The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors

Gene Therapy

Volumn 3, Issue 11, 1996, Pages 1026-1031

  Szala, S ^a   Missol, E ^a   Sochanik, A ^a   Strozyk, M ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Cationic liposomes; In vivo gene therapy; Melanoma; Suicide genes

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; LIPOSOME;

ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; ESCHERICHIA COLI; GENE THERAPY; GENE TRANSFER; INTRAPERITONEAL DRUG ADMINISTRATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CATIONS; CHOLESTEROL; CYTOSINE DEAMINASE; DRUG CARRIERS; ESCHERICHIA COLI; FLUOROURACIL; GENE TRANSFER TECHNIQUES; LIPOSOMES; MELANOMA; MICE; NEOPLASMS, EXPERIMENTAL; NUCLEOSIDE DEAMINASES; PHOSPHATIDYLETHANOLAMINES; QUATERNARY AMMONIUM COMPOUNDS;

ANIMALIA; ESCHERICHIA COLI; MURINAE;

EID: 0029857743     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5881.
2. Culver WK et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
3. Ram Z et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83-88.
4. Hirschowitz EA et ni In vivo adenovirus-mediated gene transfer of the Eschcrichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induced chemosensitivity to 5-fluorocytosine. Hum Gene Ther 1995; 6: 1055-1063.
5. Sorscher EJ et at. Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines. Gene Therapy 1994; 1: 233-238.
6. Hughes BW et al. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res 1995; 55: 3339-3345.
7. Huber BE et al. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 1994; 91: 8302-8306.
8. Freeman SM et al. The 'bystander effect : tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
9. Hoganson DK et al. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res 1996; 56: 1315-1323.
10. Ledley FD. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995; 6: 1129-1144.
11. Plautz GE et al. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci USA 1993; 90: 4645-4649.
12. Nabel GJ et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993; 90: 11307-11311.
13. Missol E, Sochanik A, Szala S. Introduction of murine IL-4 gene into B16(F10) melanoma tumors by direct gene transfer with DNA-liposome complexes. Cancer Lett 1995; 97: 189-193.
14. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Therapy 1995; 2: 710-722.
15. Gao X, Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun 1991; 179: 280-285.
16. Rose JK, Buoncore L, Whitt MA. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. BioTechniques 1991; 10: 520-525.
17. Danielsen S et al. Characterization of the Escherichia coli cod BA operon encoding cytosine permease and cytosine deaminase. Mol Microbiol 1992, 6: 1335-1344.
18. Karasuvama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 1988; 18. 97-104.
19. Yamamoto H et al. Melanin production in cultures albino melanocytes transfected with mouse tyrosinase cDNA. Jpn J Genet 1989; 64: 121-135.
20. Vile RG, Hart IR. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 1993; 53: 962-967.
21. Vile RG, Hart IR. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA Cancer Res 1993; 53: 3860-3864.
22. Mullen CA, Kilstrup M, Blaese RM. Transfer of bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA 1992; 89: 33-37.
23. Ohe Y et al. Construction of a novel bovine papilloma virus vector without detectable transforming activity suitable for gene transfer. Hum Gene Ther 1995; 6: 325-333.
24. Andreason GL, Evans GA. Optimization of electroporation for transfection of mammalian cell lines. Anal Biochem 1989; 180: 269-275.
25. Levesque JP et al. DNA transfection in COS cells: a low-cost serum-free method compared to lipofecrion. BioTechniques 1991; 11: 313-318.
26. Spiller DG, Tidd DM. Nuclear delivery of antisense oligonucleotides through reversible permeabilization of human leukemia cells with streptolysin O. Antisense Res Rev 1995; 5: 13-21.
27. Nicoletti VG, Condorelli DF. Optimized PEG method for rapid plasmid DNA purification: high yield from 'midi-prep', BioTechniques 1993; 14: 532-536.
28. Wicks IP et al. Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapy. Hum Gene Ther 1995; 6: 317-323.
29. Sugaya S et al. Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes. Hum Gene ther 1996; 7: 223-230.